Roy C. Cosan
Presidente presso Renova Therapeutics, Inc.
Profilo
Mr. Roy C.
Cosan is a Managing Director at Fjord Ventures LLC.
He is on the Board of Directors at RealBio Technology, Inc.
Mr. Cosan's experience includes 32 years with Johnson and Johnson.
He was Vice President of New Product Development at Janssen Pharmaceutica where he launched Risperdal and Reminly.
He was also a Vice President with the Johnson & Johnson Development Corp., the venture capital arm of J&J where he invested in 19 companies and held 11 board of director seats.
At J&J, he also built a virtual R&D capability for the J&J Pharma organization.
Mr. Cosan received his undergraduate degree from Western Michigan University.
Posizioni attive di Roy C. Cosan
Società | Posizione | Inizio |
---|---|---|
RealBio Technology, Inc.
RealBio Technology, Inc. BiotechnologyHealth Technology RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI. | Direttore/Membro del Consiglio | 18/05/2010 |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | Investitore di Private Equity | 01/02/2010 |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | Presidente | 01/02/2014 |
Precedenti posizioni note di Roy C. Cosan
Società | Posizione | Fine |
---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Analista di Private Equity | 31/12/2008 |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Direttore/Membro del Consiglio | 16/12/2008 |
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Direttore/Membro del Consiglio | 06/10/2006 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 31/12/1999 |
Metronom Health, Inc.
Metronom Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Metronom Health, Inc. develops and markets continuous glucose monitoring systems for diabetes management. The company was founded in 2009 Elliot B. Botvinick and Troy Bremer in 2009 and is headquartered in Laguna Hills, CA. | Amministratore Delegato | - |
Formazione di Roy C. Cosan
Western Michigan University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 11 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
RealBio Technology, Inc.
RealBio Technology, Inc. BiotechnologyHealth Technology RealBio Technology, Inc. develops cell and tissue culture technologies. It introduced D4 Culture System-an advanced, disposable cell culture platform capable of developing full three-dimensional cell structures in vitro. The firm's D4 Culture System enables customers to develop cell structures that mimic the natural composition, configuration and function of normal and diseased tissue. The company was founded by Lee Noll in June 2009 and is headquartered in Kalamazoo, MI. | Health Technology |
Metronom Health, Inc.
Metronom Health, Inc. Electronic Equipment/InstrumentsElectronic Technology Metronom Health, Inc. develops and markets continuous glucose monitoring systems for diabetes management. The company was founded in 2009 Elliot B. Botvinick and Troy Bremer in 2009 and is headquartered in Laguna Hills, CA. | Electronic Technology |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Health Technology |
Fjord Ventures Inc
Fjord Ventures Inc Investment ManagersFinance Fjord Ventures Inc (Fjord Ventures) is a venture capital firm founded in 2005 by Olav B. Bergheim. The firm is headquartered in Laguna Hills, California. | Finance |
Renova Therapeutics, Inc.
Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | Health Technology |
Prelude Corp.
Prelude Corp. BiotechnologyHealth Technology Prelude Corp. provides health related services. It offers new paradigm, predictive DCIS test, precision medicine, and clinical evidence services. The company was founded by Troy Bremer in 2009 and is headquartered in Laguna Hills, CA. | Health Technology |
Orchest Health Corp.
Orchest Health Corp. Electronic Equipment/InstrumentsElectronic Technology Orchest Health Corp. provides glucose monitoring sensors for diabetes. The company is headquartered in Laguna Hills, CA. | Electronic Technology |
- Borsa valori
- Insiders
- Roy C. Cosan